Hypertension prevalence and control in Ulaanbaatar, Mongolia

This study examines the prevalence, awareness, treatment, and control of hypertension in Ulaanbaatar, Mongolia, using both the American Heart Association and conventional thresholds (130/80 and 140/90 mm Hg, respectively). In this randomized cross‐sectional study, two‐stage cluster sampling was used to obtain a sample of 4515 individuals aged ≥20 years. Hypertension was defined by the use of antihypertensives in the last 2 weeks or a blood pressure at or above the thresholds of 140/90 and 130/80 mm Hg. The mean age of the participants was 41.1 ± 14.0 years and 54.5% were women. Hypertension prevalence was 25.6% (using 140/90 mm Hg) and 46.5% (using 130/80 mm Hg). Prevalence increased with age and below 50 years men were consistently more likely to be hypertensive. Among hypertensive participants, the rates of awareness, treatment, and control were 69.7%, 46.8%, and 24.0% (using 140/90 mm Hg) and 49.1%, 25.8%, and 6.4% (using 130/80 mm Hg, respectively). Men had lower rates of awareness, treatment, and control compared with women, with the most pronounced differences at younger ages. This study shows that awareness, treatment, and control rates in Ulaanbaatar are better than in most low‐ and middle‐income countries but are still suboptimal. The largest “care gap” was in young men where a regulatory requirement for annual workplace blood pressure screening has the potential to enhance care. A major hypertension control program has just been initiated in Ulaanbaatar.

[1]  S. Vollmer,et al.  The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults , 2019, The Lancet.

[2]  A. Bungert,et al.  Hypertension knowledge, attitudes, and practices of nurses and physicians in primary care in Ulaanbaatar Mongolia , 2019, Journal of clinical hypertension.

[3]  R. Sethi,et al.  IMPACT OF 2017 ACC/AHA GUIDELINES ON PREVALENCE OF HYPERTENSION AMONG INDIAN ADULTS: RESULTS FROM A NATIONALLY REPRESENTATIVE SURVEY , 2019, Journal of the American College of Cardiology.

[4]  Hai Su,et al.  The variance of hypertension prevalence detected by epidemiological survey against clinical practice: data from a rural population in South China. , 2018, Journal of the American Society of Hypertension : JASH.

[5]  Si‐Hyuck Kang,et al.  Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline , 2018, Scientific Reports.

[6]  H. Krumholz,et al.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study , 2018, British Medical Journal.

[7]  G. Kibria,et al.  Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline , 2018, JAMA network open.

[8]  A. Bungert,et al.  Hypertension, knowledge, attitudes, and practices of primary care physicians in Ulaanbaatar, Mongolia , 2018, Journal of clinical hypertension.

[9]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[10]  Daniel W. Jones,et al.  Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline , 2017 .

[11]  Eyal Oren,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[12]  R. Delgado-Mederos,et al.  The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage , 2016, PloS one.

[13]  F. McAlister,et al.  Epidemiology of Hypertension in Canada: An Update. , 2016, The Canadian journal of cardiology.

[14]  Jiang He,et al.  Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. , 2015, Circulation.

[15]  Atte Meretoja,et al.  Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study , 2015, Neuroepidemiology.

[16]  Tej K. Khalsa,et al.  Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee , 2014, Journal of clinical hypertension.

[17]  M. D. de Courten,et al.  Hypertension and hypertension-related disease in mongolia; findings of a national knowledge, attitudes and practices study , 2013, BMC Public Health.

[18]  N. Campbell,et al.  The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies? , 2010, Current opinion in cardiology.

[19]  Liz Smith New AHA Recommendations for Blood Pressure Measurement , 2005 .

[20]  A. Shennan,et al.  Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol , 2002, Blood pressure monitoring.

[21]  E. O’Brien,et al.  Recommendations on blood pressure measurement. , 1986, British medical journal.

[22]  Daniel W. Jones,et al.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. , 2018, Journal of the American College of Cardiology.